
Noted for their ‘vast experience both in collective actions and significant individual competition damages claims’, the lawyers at Macfarlanes LLP support clients across the market -- including in TMT, pharmaceuticals and sports -- in contentious competition matters. The firm advises on stand-alone and follow-on claims, urgent interim relief applications and abuse of dominance proceedings. The practice is led by the ’excellent and highly experienced’ Cameron Firth, who appears before the Court of Appeal and Supreme Court in appeals against CMA decisions. Malcolm Walton advises on private enforcement cases in the sports sector, with wider experience in the gambling and pharmaceuticals sectors. Simon Day is well-versed in collective action defence. Emma Radcliffe left the firm in May 2025, while Tom Usher retired in June 2025.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- Macfarlanes is quietly coming up on the rails as a leading competition firm. It is involved in many of the big cases and goes about its business in an impressively straightforward fashion. Clients love it and it is a joy to work with.
- Extraordinary depth - everyone is excellent, on top of the case conceptually and in detail. Superlative.
- Simon Day is super smart, wise, careful, and thoughtful. Cameron Firth and Rachel Carter are all really excellent.
- Malcolm Walton, Simon Day, and Alex Evans are exceptional. Malcolm is a leader of the bar, a great strategic thinker, and wonderful at breaking down complex issues for clients. Simon and Alex are both exceptionally sharp on the law and really terrific writers who can handle the most complex matters.
- The Macfarlanes team is second to none. They are sharp, hard-working, and business-minded. The Macfarlanes team always delivers.
- Strength in depth; excellent technical knowledge; good strategists, and the team is a pleasure to work with.
Key clients
- Auden Mckenzie Pharmaceuticals
- ZF Friedrichshafen
- Prysmian SpA
- Daimler Truck
- Mercedes-Benz
- NatWest Markets
- Flynn Pharma
- PRS for Music
- Arrow Generics Limited
- Perse Technology Limited
Work highlights
Advising Flynn Pharma on its successful overturning of the CMA’s remittal decision on unfair pricing and obtaining permission to appeal against the Tribunal’s remaking of the finding of unfair pricing.
Advising ZF in its defence of damages claims brought by Stellantis with the Tribunal dismissing Stellantis’ claims.
Advising PRS in its defence of proposed collective proceedings in relation to alleged unfair practices in relation to the distribution of music royalties.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Cameron Firth
Other key lawyers
Malcolm Walton; Simon Day; Caja Griesenbach; Alex Evans

